Telescope Innovations Presents Results of Second Fiscal Quarter 2025
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 24 2025
0mins
Should l Buy ?
Source: Yahoo Finance
Financial Performance: Telescope Innovations Corp reported Q2 fiscal results with revenues of CAD 1.0 million and an adjusted EBITA loss of CAD 0.4 million, while strategically reinvesting to drive growth.
Operational Developments: The company expanded its flagship product into China, launched a new accessory for its DirectInject-LC™ product, and made significant progress in collaboration with Pfizer on self-driving lab technology, alongside successful outcomes in producing battery-grade lithium carbonate.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
